Prevention of Weight Gain and Dyslipidemia by Green Tea in Patients Initiating Therapy With Olanzapine
Withdrawn before enrolling · Not applicable · Has a placebo group
Conditions studied: Bipolar Disorder, Schizophrenia
In brief
The purpose of this study is to determine if taking green tea capsules can help prevent weight gain in patients that start therapy with Zyprexa® (olanzapine).
Key facts
- Study ID
- NCT00934908
- Run by
- Medical University of South Carolina
- People needed
- 0
- Starts
- 2009-03-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2018-07-18
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Concurrently taking Zyprexa® for a psychiatric indication such as bipolar disorder or schizophrenia
- Stable body weight (+ 5%) for at least 2 weeks prior to baseline visit
- No weight loss program participation within past 3 months
You may not qualify if…
- Treatment with an atypical Anti-psychotic treatment other than olanzapine with the past 6 months
- BMI > 40 kg/m2
- Use of any dietary supplements related to weight gain or weight loss within past 1 month
- Use of any medication related to weight or plasma lipid concentration (other than hormonal contraceptives). This includes, but not limited to: antihypertensives, benzodiazepines statins, and psychostimulants.
- Uncontrolled hypertension (SBP >140 or DBP > 90 mmHg)
- Use of a hypertensive medication
- Known active alcohol or substance abuse or consumption of > three alcoholic beverages/day.
- Active cardiovascular disease
Where it is running
- Medical University of South Carolina — Charleston, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.